 Anna Euser
Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Altitude | 6 | 2024 | 488 | 0.890 |
Why?
| | Ultrasonography, Prenatal | 2 | 2015 | 285 | 0.820 |
Why?
| | Magnesium Sulfate | 3 | 2009 | 17 | 0.810 |
Why?
| | Pre-Eclampsia | 4 | 2020 | 190 | 0.780 |
Why?
| | Vasodilation | 5 | 2022 | 499 | 0.640 |
Why?
| | Pregnancy Complications | 2 | 2016 | 527 | 0.530 |
Why?
| | Chorionic Gonadotropin | 2 | 2016 | 80 | 0.520 |
Why?
| | Respiratory System Abnormalities | 1 | 2015 | 16 | 0.490 |
Why?
| | Pregnancy | 18 | 2024 | 6763 | 0.460 |
Why?
| | Diabetes, Gestational | 1 | 2018 | 318 | 0.430 |
Why?
| | Hypertension, Pregnancy-Induced | 2 | 2020 | 69 | 0.410 |
Why?
| | Aspirin | 1 | 2016 | 387 | 0.400 |
Why?
| | Blood-Brain Barrier | 3 | 2009 | 138 | 0.380 |
Why?
| | Imaging, Three-Dimensional | 1 | 2015 | 580 | 0.370 |
Why?
| | Ultrasonography | 1 | 2015 | 759 | 0.370 |
Why?
| | Polycystic Kidney, Autosomal Dominant | 1 | 2015 | 262 | 0.360 |
Why?
| | Uterine Artery | 2 | 2024 | 79 | 0.350 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2024 | 197 | 0.350 |
Why?
| | Brain Edema | 2 | 2007 | 61 | 0.320 |
Why?
| | Altitude Sickness | 2 | 2022 | 153 | 0.320 |
Why?
| | Eclampsia | 1 | 2009 | 4 | 0.310 |
Why?
| | Cerebrovascular Circulation | 2 | 2007 | 243 | 0.280 |
Why?
| | Kidney | 1 | 2015 | 1468 | 0.270 |
Why?
| | Anticonvulsants | 1 | 2009 | 217 | 0.260 |
Why?
| | Pregnancy Complications, Infectious | 2 | 2023 | 394 | 0.250 |
Why?
| | Tocolytic Agents | 1 | 2004 | 16 | 0.230 |
Why?
| | Epilepsy | 1 | 2009 | 333 | 0.230 |
Why?
| | Potassium Chloride | 1 | 2024 | 38 | 0.220 |
Why?
| | Pregnancy, Animal | 1 | 2004 | 52 | 0.220 |
Why?
| | Nitric Oxide Synthase | 2 | 2019 | 240 | 0.210 |
Why?
| | Magnetic Resonance Imaging | 1 | 2015 | 3566 | 0.210 |
Why?
| | Intestinal Atresia | 1 | 2023 | 15 | 0.200 |
Why?
| | Homeostasis | 1 | 2007 | 621 | 0.200 |
Why?
| | Vasodilator Agents | 1 | 2004 | 331 | 0.200 |
Why?
| | Abortion, Induced | 1 | 2024 | 105 | 0.190 |
Why?
| | Arteries | 2 | 2022 | 269 | 0.190 |
Why?
| | Female | 19 | 2024 | 73304 | 0.180 |
Why?
| | Fetal Development | 1 | 2024 | 296 | 0.180 |
Why?
| | Adult | 11 | 2024 | 37929 | 0.160 |
Why?
| | Myometrium | 1 | 2020 | 39 | 0.160 |
Why?
| | Nuchal Translucency Measurement | 1 | 2019 | 3 | 0.160 |
Why?
| | Fetal Growth Retardation | 2 | 2024 | 565 | 0.150 |
Why?
| | Amniotic Fluid | 1 | 2019 | 96 | 0.150 |
Why?
| | Maternal Age | 1 | 2018 | 129 | 0.140 |
Why?
| | Parity | 1 | 2018 | 126 | 0.140 |
Why?
| | Protein Kinases | 1 | 2020 | 319 | 0.140 |
Why?
| | Chi-Square Distribution | 1 | 2018 | 530 | 0.140 |
Why?
| | Body Water | 2 | 2007 | 21 | 0.140 |
Why?
| | Microcephaly | 1 | 2018 | 98 | 0.130 |
Why?
| | Rats, Sprague-Dawley | 3 | 2007 | 2486 | 0.130 |
Why?
| | Zika Virus | 1 | 2018 | 128 | 0.130 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2019 | 446 | 0.130 |
Why?
| | Pregnancy, Twin | 1 | 2016 | 19 | 0.130 |
Why?
| | Regression Analysis | 1 | 2018 | 1024 | 0.120 |
Why?
| | Incidence | 2 | 2023 | 2804 | 0.120 |
Why?
| | Metabolome | 1 | 2019 | 350 | 0.120 |
Why?
| | Zika Virus Infection | 1 | 2018 | 165 | 0.120 |
Why?
| | Single-Blind Method | 1 | 2015 | 282 | 0.120 |
Why?
| | Young Adult | 5 | 2024 | 13209 | 0.110 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1509 | 0.110 |
Why?
| | Pregnancy, Multiple | 1 | 2014 | 17 | 0.110 |
Why?
| | ROC Curve | 1 | 2016 | 554 | 0.110 |
Why?
| | Placenta | 1 | 2021 | 750 | 0.110 |
Why?
| | Humans | 16 | 2024 | 137585 | 0.110 |
Why?
| | Retrospective Studies | 4 | 2024 | 15657 | 0.110 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2014 | 77 | 0.110 |
Why?
| | Fetal Diseases | 1 | 2015 | 173 | 0.100 |
Why?
| | Prenatal Care | 1 | 2016 | 294 | 0.100 |
Why?
| | Rats | 3 | 2007 | 5647 | 0.100 |
Why?
| | Endothelium, Vascular | 1 | 2019 | 927 | 0.100 |
Why?
| | Pregnancy in Diabetics | 1 | 2014 | 123 | 0.090 |
Why?
| | Hypertension | 2 | 2014 | 1295 | 0.090 |
Why?
| | Prevalence | 1 | 2018 | 2734 | 0.090 |
Why?
| | Gene Expression Regulation | 1 | 2021 | 2607 | 0.090 |
Why?
| | Hypoxia | 3 | 2024 | 1112 | 0.090 |
Why?
| | Signal Transduction | 2 | 2024 | 5079 | 0.090 |
Why?
| | Double-Blind Method | 1 | 2016 | 1993 | 0.090 |
Why?
| | Risk Factors | 3 | 2019 | 10388 | 0.080 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2007 | 13 | 0.070 |
Why?
| | Evans Blue | 1 | 2007 | 7 | 0.070 |
Why?
| | Coloring Agents | 1 | 2007 | 87 | 0.070 |
Why?
| | Permeability | 1 | 2007 | 161 | 0.070 |
Why?
| | NG-Nitroarginine Methyl Ester | 1 | 2007 | 48 | 0.070 |
Why?
| | Aquaporin 4 | 1 | 2007 | 94 | 0.070 |
Why?
| | Fluorescein | 1 | 2007 | 25 | 0.070 |
Why?
| | Laser-Doppler Flowmetry | 1 | 2007 | 32 | 0.070 |
Why?
| | Phenylephrine | 1 | 2007 | 75 | 0.070 |
Why?
| | Infant, Newborn | 3 | 2024 | 6079 | 0.060 |
Why?
| | Capillary Permeability | 1 | 2007 | 145 | 0.060 |
Why?
| | Vasoconstrictor Agents | 1 | 2007 | 139 | 0.060 |
Why?
| | Fluorescent Dyes | 1 | 2007 | 321 | 0.060 |
Why?
| | Mesenteric Arteries | 1 | 2004 | 16 | 0.060 |
Why?
| | Blotting, Western | 1 | 2007 | 1226 | 0.060 |
Why?
| | Pregnancy Trimester, Second | 1 | 2024 | 80 | 0.060 |
Why?
| | Cerebral Arteries | 1 | 2004 | 59 | 0.060 |
Why?
| | Pregnancy Trimester, Third | 1 | 2024 | 114 | 0.050 |
Why?
| | Injections | 1 | 2024 | 183 | 0.050 |
Why?
| | Fetus | 2 | 2019 | 806 | 0.050 |
Why?
| | Vascular Resistance | 1 | 2004 | 375 | 0.050 |
Why?
| | Enzyme Inhibitors | 1 | 2007 | 840 | 0.050 |
Why?
| | Animals | 4 | 2022 | 36940 | 0.050 |
Why?
| | Blood Pressure | 2 | 2020 | 1786 | 0.050 |
Why?
| | Regional Blood Flow | 1 | 2024 | 474 | 0.050 |
Why?
| | Potassium Channels | 1 | 2022 | 151 | 0.050 |
Why?
| | Postpartum Period | 1 | 2004 | 340 | 0.050 |
Why?
| | Birth Weight | 1 | 2024 | 516 | 0.040 |
Why?
| | Gestational Age | 1 | 2024 | 910 | 0.040 |
Why?
| | Pyrones | 1 | 2020 | 8 | 0.040 |
Why?
| | Pregnancy Outcome | 1 | 2023 | 416 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2022 | 491 | 0.040 |
Why?
| | Biphenyl Compounds | 1 | 2020 | 63 | 0.040 |
Why?
| | Thiophenes | 1 | 2020 | 117 | 0.040 |
Why?
| | United States | 1 | 2016 | 14841 | 0.040 |
Why?
| | Infant | 2 | 2023 | 9465 | 0.030 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2014 | 3715 | 0.030 |
Why?
| | Epidemics | 1 | 2018 | 89 | 0.030 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2018 | 184 | 0.030 |
Why?
| | Neuroimaging | 1 | 2018 | 259 | 0.030 |
Why?
| | Nitric Oxide | 1 | 2020 | 915 | 0.030 |
Why?
| | Brain | 1 | 2007 | 2668 | 0.030 |
Why?
| | Endoglin | 1 | 2014 | 19 | 0.030 |
Why?
| | Placenta Growth Factor | 1 | 2014 | 24 | 0.030 |
Why?
| | Ribonuclease, Pancreatic | 1 | 2014 | 12 | 0.030 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 1 | 2014 | 43 | 0.030 |
Why?
| | Pregnancy Proteins | 1 | 2014 | 36 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2014 | 71 | 0.030 |
Why?
| | Progesterone | 1 | 2014 | 254 | 0.020 |
Why?
| | Receptors, Cell Surface | 1 | 2014 | 385 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2019 | 3556 | 0.020 |
Why?
| | Antigens, CD | 1 | 2014 | 521 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 1242 | 0.020 |
Why?
| | Risk Assessment | 1 | 2014 | 3457 | 0.010 |
Why?
| | Child | 1 | 2023 | 21935 | 0.010 |
Why?
| | Biomarkers | 1 | 2014 | 4149 | 0.010 |
Why?
| | Adolescent | 1 | 2019 | 21513 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 33479 | 0.010 |
Why?
|
|
Euser's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|